Results 111 to 120 of about 374 (149)
Some of the next articles are maybe not open access.
Aminocaproic Acid Prophylaxis in Traumatic Hyphema
Ophthalmic Surgery, Lasers and Imaging Retina, 1990ABSTRACT Oral aminocaproic acid has been shown to be effective in clot stabilization and in the reduction of secondary bleeding rates in cases of traumatic hyphema. In a retrospective study of 105 patients treated during a 1-year period, we found the incidence of rebleeding in patients with traumatic hyphema who received aminocaproic acid ...
Thomas W. Wilson +2 more
openaire +3 more sources
Spectrophotometric Assays for l-Lysine α-Oxidase and γ-Glutamylamine Cyclotransferase
, 2002A new assay for l -lysine α-oxidase is described. In this assay, the oxidized product generated from l -lysine is reacted with semicarbazide to form α-keto-ϵ-aminocaproate semicarbazone.
J. Danson +2 more
semanticscholar +1 more source
The sequence around the active-center tyrosyl of porcine carboxypeptidase B.
European Journal of Biochemistry, 1971Iodination of porcine carboxypeptidase B causes a loss of both peptidase and esterase activity; the presence of the inhibitor β-phenylpropionate during iodination prevents the loss.
O. Roholt, D. Pressman
semanticscholar +1 more source
Effect of probenecid on the kinetics of epsilon-aminocaproic acid
Clinical Pharmacology and Therapeutics, 1980Healthy male subjects received, 1 wk apart, single oral doses of epsilon-aminocaproic acid (EACA) 100 mg/kg alone, EACA within probenecid (0.5 gm), or EACA 2 hr after 2.0 gm probenecid. Probenecid (2.0 gm) reduced the 8-hr urinary clearance and recovery of EACA by 50% without affecting plasma kinetics.
Kerry L Katlic +3 more
openaire +3 more sources
Myoglobinuria Following Aminocaproic Acid Administration
JAMA: The Journal of the American Medical Association, 1976To the Editor.— e-Aminocaproic acid (EACA), a specific inhibitor of plasminogen activation, was originally used in low dosage as an antifibrinolytic agent and is now being employed in higher doses in the treatment of hereditary angioneurotic edema. We have recently encountered a 24-year-old woman receiving high doses of EACA who had rhabdomyolysis and
Robert A. Rizza +2 more
openaire +2 more sources
Degradation Mechanisms of Nylon Separator Materials for a Nickel‐Cadmium Cell in KOH Electrolytes
, 1989Degradation reactions of a nylon 6 battery separator material have been studied in 4-34% aqueous KOH electrolytes at 35/sup 0/-110/sup 0/C. In a Ni/Cd cell, this degradation involves a slow hydrolysis reaction followed by fast electrochemical oxidations ...
H. Lim +4 more
semanticscholar +1 more source
Rhabdomyolysis Induced by Epsilon-Aminocaproic Acid
Annals of Pharmacotherapy, 1997OBJECTIVE: To report a case of rhabdomyolysis associated with epsilon-aminocaproic acid (epsilon-ACA). CASE SUMMARY: A 33-year-old female patient with chronic granulocytic leukemia was treated with epsilon-ACA for approximately 3.5 months for thrombocytopenic bleeding. The initial dosage was 4 g po q6h.
Morel Rubinger, Beverly D Seymour
openaire +3 more sources
Thrombosis with Epsilon Aminocaproic Acid Therapy
American Journal of Clinical Pathology, 1971A patient with postoperative bleeding was treated with epsilon aminocaproic acid (EACA). Subsequent coagulation studies supported the diagnosis of intravascular coagulation and the patient subsequently developed renal failure due to glomerular thromboses.
Harvey R. Gralnick, Philip Greipp
openaire +3 more sources
Aminocaproic Acid in the Treatment of Traumatic Hyphema
American Journal of Ophthalmology, 1976Of 59 patients with traumatic hyphema studied prospectively, 32 received aminocaproic acid, an antifibrinolytic agent, to prevent secondary hemorrhage. The remaining 27 patients received placebo in an identical manner. Of the aminocaproic acid-treated patients, only one (3%) rebled, while nine patients (33%) receiving placebo suffered secondary ...
Earl R. Crouch, Marcel Frenkel
openaire +3 more sources
Effect of -Aminocaproic Acid on Postvitrectomy Hemorrhage
Archives of Ophthalmology, 1985We performed a prospective study involving 96 patients undergoing vitrectomy for proliferative diabetic retinopathy to determine the effect of epsilon-aminocaproic acid on the occurrence of postoperative intraocular hemorrhage. epsilon-Aminocaproic acid significantly reduced postoperative vitreous hemorrhage during the immediate postoperative period ...
S. De Bustros +3 more
openaire +3 more sources